Examination and Treatment of Deep Vein Thrombosis (DVT)
For patients with suspected DVT, initial evaluation should be performed with compression ultrasonography (CUS) of the proximal veins or whole-leg ultrasonography, followed by appropriate anticoagulation therapy if positive. 1
Diagnostic Approach
Risk Stratification
Assess pretest probability of DVT using clinical features:
- Localized pain and swelling
- Erythema of affected limb
- Dilated superficial veins
- Risk factors (immobility, recent surgery, cancer, etc.)
Categorize patients into risk groups:
- Low pretest probability: Use highly sensitive D-dimer test first
- Moderate pretest probability: Either highly sensitive D-dimer or proximal CUS
- High pretest probability: Proceed directly to proximal CUS or whole-leg US
Diagnostic Testing Algorithm
For Low Pretest Probability:
- Perform highly sensitive D-dimer test
- If D-dimer negative → No further testing needed (DVT ruled out)
- If D-dimer positive → Proceed to proximal CUS
For Moderate Pretest Probability:
- Perform highly sensitive D-dimer (preferred) or proximal CUS
- If D-dimer negative → No further testing needed
- If D-dimer positive → Perform proximal CUS
- If proximal CUS negative but D-dimer positive → Repeat CUS in 1 week
For High Pretest Probability:
- Perform proximal CUS or whole-leg US
- If positive → Treat for DVT
- If negative → Additional testing with highly sensitive D-dimer, whole-leg US, or repeat proximal CUS in 1 week
Special Considerations
- Pregnant patients: Initial evaluation with proximal CUS is recommended 1
- Upper extremity DVT: Combined modality US (compression with Doppler or color Doppler) is suggested 1
- Isolated iliac vein thrombosis: Consider Doppler US of iliac vein, venography, or MRI 1
- When US is impractical (leg casting, excessive tissue): Consider CT venography or MR venography 1
Treatment of Confirmed DVT
Initial Treatment
For patients with confirmed DVT, anticoagulation should be initiated immediately:
Parenteral anticoagulation options:
- Enoxaparin 1 mg/kg subcutaneously every 12 hours (outpatient treatment for DVT without PE)
- Enoxaparin 1 mg/kg every 12 hours or 1.5 mg/kg once daily (inpatient treatment) 2
Oral anticoagulation transition:
Duration of Treatment
- First episode with transient risk factor: 3 months 3
- First episode of idiopathic DVT: 6-12 months 3
- Two or more episodes: Indefinite treatment 3
- DVT with thrombophilic conditions: 6-12 months with consideration for indefinite therapy 3
Treatment Monitoring
- Target INR of 2.0-3.0 for patients on warfarin 3
- Follow-up ultrasound examinations are warranted only in specific situations:
- Patients with isolated calf vein thrombosis who have contraindications to anticoagulation
- Patients with recurrent symptoms
- To establish a baseline after completion of therapy in patients at risk for recurrence 4
Important Clinical Considerations
- Whole-leg US is preferred for patients unable to return for serial testing and those with severe symptoms consistent with calf DVT 1
- If isolated distal DVT is detected on whole-leg US, serial testing to rule out proximal extension is suggested over immediate treatment 1
- Left leg DVT is more common (50% of cases) than right leg DVT (33%) 5
- Most common sites of DVT are popliteal vein (77%), superficial femoral vein (76%), and common femoral vein (65%) 5
- VDUS is positive in 90% of PE patients with leg symptoms but only 20% of PE patients without leg symptoms 5
Pitfalls to Avoid
- Do not rely solely on D-dimer testing in high pretest probability patients 1
- Do not use anticoagulant management based on ultrasound findings alone; therapy should be guided by clinical trial evidence 4
- Avoid unnecessary follow-up ultrasonography during anticoagulant treatment in the absence of new symptoms 4
- Do not omit examination of the superficial femoral vein as this would decrease the sensitivity of ultrasound 5
- In patients with extensive unexplained leg swelling with negative proximal or whole-leg US, remember to image iliac veins to exclude isolated iliac DVT 1